Hypericum monogynum
What's the taxonomical classification of Hypericum monogynum?
Hypericum monogynum belongs to the kingdom Plantae and is classified within the phylum Streptophyta. As a member of the class Equisetopsida and the subclass Magnoliidae, it falls under the order Malpighiales. The plant is further categorized into the family Hypericaceae, which contains the genus Hypericum, and is specifically identified by the species name monogynum.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Hypericaceae |
| Genus | Hypericum |
| Species | monogynum |
What are the morphological characteristics of this plant?
Hypericum monogynum has an erect, woody-based perennial structure characterized by opposite, elliptical leaves with prominent translucent glandular dots and yellow five-petaled flowers featuring numerous long stamens. The stems are typically branched and can reach heights of up to 60 centimeters, often exhibiting a slightly woody texture at the base. The foliage consists of small, dark green leaves that are arranged in pairs along the stem. Each inflorescence produces bright yellow petals that surround a central cluster of many stamens, which is a defining trait of the genus. After blooming, the plant develops small, rounded seed capsules that facilitate its reproduction.
What is the geographical distribution of this plant?
This plant is native to the Mediterranean region, specifically spanning across parts of Southern Europe, North Africa, and Western Asia. It thrives in various habitats ranging from coastal dunes to rocky hillsides and open woodlands. Due to its adaptability, it can be found in diverse climates characterized by seasonal rainfall and mild temperatures. Some populations have also become naturalized in other temperate regions outside its original range. Its presence is often dictated by soil quality and sunlight exposure within these specific zones.
How is this plant cultivated?
This plant Hypericum monogynum thrives when grown in well-drained, fertile soil with full sun exposure and regular moisture.
It prefers temperate climates where it can develop its characteristic bright yellow flowers throughout the summer months. To ensure healthy growth, gardeners should provide consistent watering while avoiding waterlogged conditions that can lead to root rot. Pruning the shrubs in late winter or early spring helps maintain a compact shape and encourages vigorous new blooming.
This species is particularly valued in landscaping for its ability to add vibrant color and texture to garden borders.
What parts of this plant are used medicinally?
This plant Hypericum monogynum is utilized medicinally through its flowers, leaves, roots, and twigs. The vibrant flowers and green leaves are often harvested to create infusions or oils used for their soothing topical properties. Medicinal preparations may also incorporate the roots to address various internal ailments through decoctions. Even the woody twigs are sometimes included in herbal blends to enhance the overall potency of a remedy. Each of these specific parts contains unique bioactive compounds that contribute to its therapeutic value.
According to a study published by "Phytochemistry", the flowers of Hypericum monogynum L. have been used as a folk Chinese medicine for the treatment of inflammatory related diseases. A chemical constituent study identified sixteen chemical monomers from these flowers, which included three undescribed oxidative degradation polycyclic polyprenylated acylphloroglucinol (PPAPs, hypemoins C-E) and two undescribed PPAPs (hypemoins A and B) along with 11 known compounds. Four flavonoid derivatives demonstrated remarkable COX-2 inhibitory activities with IC50 values ranging from 0.220 ± 0.006 to 1.655 ± 0.098 μM. Molecular docking analysis predicted the possible recognition mechanism between quercetin 3-(6″-O-caffeoyl)-β-3-D-galactoside and COX-2.
The parts of this plant that are ued medicinally are shown in the list below.
- flower
- leaves
- roots
- twigs
What traditional systems uses this plant?
This plant Hypericum monogynum has been utilized throughout various historical medical traditions to address diverse physical and psychological ailments. In Traditional Chinese Medicine, specific species within the Hypericum genus are often employed to regulate the flow of Qi and clear heat from the body. Historical practitioners frequently applied extracts from the plant to treat topical wounds and skin inflammations due to its perceived antiseptic properties. Some ancient records also suggest its use in managing mild depressive symptoms and anxiety through its influence on the nervous system. These long-standing practices reflect a deep historical understanding of the botanical's bioactive potential.
According to a study published by "Phytochemistry", Hypericum monogynum L. has been used as a folk Chinese medicine for the treatment of inflammatory related diseases. Researchers identified sixteen chemical monomers from the flowers of the plant, which included 3 undescribed oxidative degradation polycyclic polyprenylated acylphloroglucinols known as hypemoins C-E and 2 undescribed PPAPs known as hypemoins A and B. The study also identified 11 known compounds within the plant's flowers. Four flavonoid derivatives demonstrated remarkable COX-2 inhibitory activities with IC50 values ranging from 0.220 ± 0.006 to 1.655 ± 0.098 μM.
The hystorical systems that uses this plant are shown in the list below.
- Traditional Chinese Medicine
What are the pharmacological activities of Hypericum monogynum?
This plant has antidepressant, anti-inflammatory, anti-tumor, cytotoxicity, and multidrug resistance reversal pharmacological activities. Its bioactive compounds function by modulating neurotransmitters to alleviate symptoms of depression. The plant also demonstrates significant anti-inflammatory properties by inhibiting specific chemical mediators of inflammation. In oncological research, it exhibits potent cytotoxicity against various cancer cell lines to inhibit tumor growth. Furthermore, it plays a crucial role in multidrug resistance reversal, making it more effective at overcoming cellular defenses against chemotherapy.
According to a study published by "Journal of natural products", ten new polyprenylated tetraoxygenated xanthones, monogxanthones A-J (1-10), were identified from the roots of Hypericum monogynum. Compounds 1 and 2 exhibited neuroprotective effects against corticosterone-induced lesions of PC12 cells at concentrations of 6.25, 12.50, and 25.00 μM, maintaining cell viability greater than 75%. These same compounds also showed inhibitory effects on nitric oxide production in lipopolysaccharide-induced BV2 microglia cells. The IC50 values for these inhibitory effects were recorded as 7.47 ± 0.65 and 9.60 ± 0.12 μM, respectively. These findings suggest that polyprenylated xanthones from this genus have potential in the development of antidepresson therapies.
The primary pharmacological activities of this plant are shown in the list below.
- antidepressant
- anti-inflammatory
- anti-tumor
- cytotoxicity
- neuroprotective
What medicinal compounds this plant contains?
This plant contains hyperforin, hypericin, hyperoside, flavone, and polyprenylated acylphloroglucinol (PPAPs) as its primary medicinal compounds. Hyperforin is a major constituent often studied for its antidepressant properties and ability to influence neurotransmitter reuptake. Hypericin serves as a key naphthodianthrone that contributes to the plant's biological activity. The presence of hyperoside and various flavone glycosides provides additional antioxidant and anti-inflammatory benefits. Furthermore, the group of polyprenylated acylphloroglucinol (PPAPs) compounds offers diverse pharmacological potential in many therapeutic applications.
According to a study published by "Horticulture research", Hypericum monogynum contains abundant hyperoside in its flower buds. This bioactive flavonoid galactoside plays an important physiological role in the growth of flower buds. The biosynthesis of hyperoside in this plant involves 4 kinds of key enzymes including HmF3Hs, HmFLSs, HmF3'H, and HmGAT. Specifically, HmF3'H acts on 4'-hydroxyl flavonoids to produce 3',4'-dihydroxylated flavanone, dihydroflavonols, flavonols, and flavones. The HmGAT enzyme transforms flavonols into 3-O-galactosides such as hyperoside.
The primary medicinal compounds of this plant are shown in the list below.
- hypericin
- hyperforin
- pseudohypericin
- hyperoside
- quercetin-3-O-β-d-galactopyranoside
What health conditions is this plant used for?
This plant is used for treating depression, inflammatory related diseases, chemical-induced injuries, corticosterone (Cort)-induced lesions, and lipopolysaccharide-induced BV2 microglia cells inflammation. Its therapeutic properties are often studied for their potential to mitigate neuroinflammation and restore psychological balance. Researchers investigate how its bioactive compounds can protect the nervous system from damage caused by chemical stressors. Furthermore, the plant shows promise in reducing cellular inflammation triggered by specific biological agents like lipopolysaccharides. These various applications highlight its significant role in addressing complex neurological and inflammatory conditions.
According to a study published by "Journal of natural products", the roots of Hypericum monogynum contain ten new polyprenylated tetraoxygenated xanthones labeled monogxanthones A-J (1-10) and eight known analogues (4b, 11-17). Compounds 1 and 2 from the plant demonstrated neuroprotective effects against corticosterone-induced lesions of PC12 cells at concentrations of 6.25, 12.50, and 25.00 μM while maintaining cell viability greater than 75%. These compounds also showed inhibitory effects on nitric oxide production in lipopolysaccharide-induced BV2 microglia cells with IC50 values of 7.47 ± 0.65 and 9.60 ± 0.12 μM. These findings suggest a potential for these xanthones in the development of antidepression therapies.
The main health conditions this plant is used for are shown in the list below.
- depression
- inflammatory related diseases
- chemical-induced injuries
- corticosterone (Cort)-induced lesions
- lipopolysaccharide-induced BV2 microglia cells inflammation
What are the herbal preparations of this plant?
This plant is Hypericum monogynum, a species used to create various medicinal herbal preparations such as tinctures, oils, and standardized Hypericum monogynum extract. These preparations often utilize the flowering tops of the plant to concentrate active phytochemicals like hypericin and hyperforin. Many topical oil formulations are crafted to support skin health and soothe minor irritations. Oral extracts are frequently studied for their potential influence on mood regulation and neurological balance. Consistent quality in these preparations depends on the specific extraction method and the concentration of bioactive compounds used.
According to a study published by "Chinese journal of natural medicines", chipericumin D is a natural compound extracted from Hypericum monogynum L. that was identified after an in-house library of 88 compounds was screened via dot-blotting. This extract exhibits potent inhibitory activity against the osteogenic differentiation of human aortic valve interstitial cells. Research using network pharmacology analysis, molecular docking, drug affinity responsive target stability, cellular thermal shift assay, and surface plasmon resonance demonstrated that chipericumin D directly binds to the epidermal growth factor receptor. Furthermore, chipericumin D suppressed the activation of the EGFR/phosphatidylinositol 3-kinase/protein kinase B signaling pathway in cells cultured under osteogenic medium conditions. These findings suggest chipericumin D is a promising therapeutic candidate for calcific aortic valve disease.
The main herbal preparations of this plant are shown in the list below.
- Hypericum monogynum extract
What side effects this plant can have?
This plant can cause significant health side effects including insulin resistance, photosensitivity, and dangerous interactions with various prescription medications. When consumed, it may interfere with how the body processes glucose, potentially leading to elevated blood sugar levels. Many users also experience increased sensitivity to sunlight, which can result in skin rashes or severe burns. Furthermore, its ability to induce liver enzymes can reduce the effectiveness of antidepressants, birth control, and blood thinners. These complications make it essential to consult a medical professional before use.
According to a study published by "Journal of medicinal food", two high-content flavonoid derivatives, HM 104 and HM 111, were isolated from Hypericum monogynum flowers. These compounds, identified as 3-8 biapigenin and quercetin-3-O-beta-d-galactopyranoside, exhibited good glucose consumption in fatty acid-induced insulin-resistant HepG2 cells. Both HM 104 and HM 111 enhanced glucose uptake by restoring the expression of regulators such as insulin receptor substrate 1 and glucose transporter type 4. The derivatives also mitigated the expression of forkhead box O1 and factors involved in gluconeogenesis while upregulating the phosphorylation of glycogen synthase kinase-3beta. Additionally, the production of reactive oxygen species was decreased by these two compounds.
The main side effects this plant can have are shown in the list below.
- insulin resistance
What herbs are paired with Hypericum monogynum?
This plant, Hypericum monogynum, pairs effectively with aromatic herbs such as lavender, rosemary, and lemon balm to enhance its botanical profile in various infusions.
These combinations are often utilized in herbal blends to balance the plant's natural potency with soothing or uplifting scents. Lavender provides a floral counterpoint that complements the subtle notes of the Hypericum. Rosemary adds a woody depth, while lemon balm offers a bright, citrusy undertone to the mixture.
Selecting these specific pairings allows for a more nuanced sensory experience during use.